Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.

ClinicalTrials.gov ID: NCT00077636

Public ClinicalTrials.gov record NCT00077636. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 13, 2026, 4:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-label Study of the Effect of PEGASYS and Ribavirin Combination Therapy on Sustained Virologic Response in Interferon-naïve Patients With Chronic Hepatitis C Genotype 2 or 3 Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the efficacy and safety of different durations of treatment with PEGASYS combined with ribavirin in patients with CHC genotype 2 or 3 infection who have never previously received interferon (IFN) therapy. The anticipated time on study treatment is 3-12 months and the target sample size is 500+ individuals.

Study identification

NCT ID
NCT00077636
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
1,469 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2003
Primary completion
Feb 28, 2006
Completion
Feb 28, 2006
Last update posted
Feb 22, 2016

2003 – 2006

United States locations

U.S. sites
88
U.S. states
35
U.S. cities
78
Facility City State ZIP Site status
Not listed Birmingham Alabama 35294
Not listed Mobile Alabama 36693
Not listed Anchorage Alaska 99508
Not listed Phoenix Arizona 85006
Not listed Scottsdale Arizona 85259
Not listed Little Rock Arkansas 72205
Not listed La Jolla California 92037-1030
Not listed Long Beach California 90822
Not listed Los Angeles California 90048
Not listed Palo Alto California 94304-1509
Not listed Sacramento California 95825-2115
Not listed San Diego California 92105
Not listed San Diego California 92123
Not listed San Diego California 92154
Not listed San Francisco California 94115
Not listed San Francisco California 94121
Not listed San Luis Obispo California 93401
Not listed Littleton Colorado 80120
Not listed Farmington Connecticut 06030
Not listed Bradenton Florida 34209
Not listed Gainesville Florida 32610-0214
Not listed Jacksonville Florida 32207
Not listed Jacksonville Florida 32209
Not listed Miami Florida 33136
Not listed Orlando Florida 32803
Not listed Pensacola Florida 32514
Not listed Tampa Florida 33612
Not listed Wellington Florida 33414
Not listed Atlanta Georgia 30309
Not listed Austell Georgia 30106
Not listed Honolulu Hawaii 96817
Not listed Boise Idaho 83702
Not listed Moline Illinois 61265
Not listed Indianapolis Indiana 46202
Not listed Iowa City Iowa 52242
Not listed Iowa City Iowa 52246
Not listed Baton Rouge Louisiana 70805
Not listed New Orleans Louisiana 70112
Not listed Baltimore Maryland 21201
Not listed Baltimore Maryland 21205
Not listed Boston Massachusetts 02118
Not listed Boston Massachusetts 02720
Not listed Burlington Massachusetts 01805
Not listed Worcester Massachusetts 01655
Not listed Ann Arbor Michigan 48109-0362
Not listed Detroit Michigan 48202-2689
Not listed Minneapolis Minnesota 55417
Not listed Plymouth Minnesota 55446
Not listed St Louis Missouri 63104
Not listed Albuquerque New Mexico 87108
Not listed Bayside New York 11358
Not listed Binghamton New York 13903
Not listed Manhasset New York 11030
Not listed New York New York 10003
Not listed New York New York 10021
Not listed The Bronx New York 10468
Not listed Williamsville New York 14221
Not listed Chapel Hill North Carolina 27599-7584
Not listed Durham North Carolina 27710
Not listed Fayetteville North Carolina 28304
Not listed Statesville North Carolina 28677
Not listed Cincinnati Ohio 45267-0595
Not listed Cleveland Ohio 44106
Not listed Portland Oregon 97220
Not listed Hershey Pennsylvania 17033
Not listed Lancaster Pennsylvania 17604-3200
Not listed Pittsburgh Pennsylvania 15213
Not listed Cranston Rhode Island 02920
Not listed Providence Rhode Island 02905
Not listed Germantown Tennessee 38138
Not listed Dallas Texas 75203
Not listed Dallas Texas 75235-9151
Not listed Fort Sam Houston Texas 78234-3879
Not listed Houston Texas 77030
Not listed Salt Lake City Utah 84121
Not listed White River Junction Vermont 05009-0001
Not listed Charlottesville Virginia 22902
Not listed Chesapeake Virginia 23320-1706
Not listed Falls Church Virginia 22042
Not listed Richmond Virginia 23249
Not listed Bellevue Washington 98004
Not listed Kirkland Washington 98034
Not listed Puyallup Washington 98372
Not listed Seattle Washington 98133
Not listed Seattle Washington 98195
Not listed Spokane Washington 99220-3649
Not listed Madison Wisconsin 53792
Not listed Cheyenne Wyoming 82001

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00077636, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 22, 2016 · Synced Sep 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00077636 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →